Mirador Capital Partners LP Brainstorm Cell Therapeutics Inc. Transaction History

Mirador Capital Partners LP

  • $529 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 05, 2023
BUY
$0.2 - $2.08 $288 - $2,997
1,441 Added 5.74%
26,525 $5,000
Q2 2023

Aug 14, 2023
BUY
$2.0 - $3.2 $50,168 - $80,268
25,084 New
25,084 $51,000

Others Institutions Holding BCLI

# of Institutions
38
Shares Held
10.6M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $73.7M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Mirador Capital Partners LP Portfolio

Follow Mirador Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email